Imricor Medical Systems (ASX:IMR) reported on Wednesday a loss of $0.08 per share in 2025, compared with $0.13 a year earlier.
Analysts polled by FactSet expected a loss of $0.08.
Total revenue for the 12 months ended Dec. 31, 2025, was $292,309 compared with $959,424 a year earlier.
The board did not declare a final dividend for the year.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.